Pancreatic Cancer Research

ResearcherSichuan UniversityNo recent work listed

Zhenlu Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2101-8237; OpenAlex author ID A5030930581. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: 3 papers

Papers 5

  1. Prognostic value of systemic immune-inflammation index in patients with pancreatic cancer: a meta-analysis. First author DOI 10.1007/s10238-021-00785-x↗
  2. Down-regulation of USP22 reduces cell stemness and enhances the sensitivity of pancreatic cancer cells to cisplatin by inactivating the Wnt/β-catenin pathway. Co-author DOI 10.1016/j.tice.2022.101787↗
  3. Long non-coding RNA DSCAM-AS1 promotes pancreatic cancer progression via regulating the miR-136-5p/PBX3 axis. Co-author DOI 10.1080/21655979.2021.2016326↗
  4. Long Non-Coding RNA MIR4435-2HG Promotes Glycolysis and Tumor Immunity in Pancreatic Cancer Through Absorption of microRNA-582-5p to Target GPX8 Co-author DOI 10.21203/rs.3.rs-1112369/v1↗
  5. Oral microbiome and pancreatic cancer. Co-author DOI 10.3748/wjg.v26.i48.7679↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huimin Lü · 3 shared papers, 2021–2022 · strength 0.55
  2. Li Mao · 3 shared papers, 2020–2022 · strength 0.43
  3. Weiming Hu · 2 shared papers, 2022 · strength 0.41
  4. Xing Huang · 2 shared papers, 2022 · strength 0.40
  5. Zihe Wang · 2 shared papers, 2022 · strength 0.36
  6. Weiming Hu · 2 shared papers, 2021–2022 · strength 0.31
  7. Huimin Lu · 1 shared paper, 2022 · strength 0.17
  8. DuJiang Yang · 1 shared paper, 2021 · strength 0.14
  9. Jue Yuan · 1 shared paper, 2020 · strength 0.10
  10. Hongying Liu · 1 shared paper, 2020 · strength 0.10
  11. Ailin Wei · 1 shared paper, 2020 · strength 0.10
  12. Ang Li · 1 shared paper, 2020 · strength 0.10
  13. Mei Rosemary Fu · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.